- Oxaliplatin plus irinotecan compared with irinotecan alone as second-line treatment after single-agent fluoropyrimidine therapy for metastatic colorectal carcinoma. Haller, D.G., Rothenberg, M.L., Wong, A.O., Koralewski, P.M., Miller, W.H., Bodoky, G., Habboubi, N., Garay, C., Olivatto, L.O. J. Clin. Oncol. (2008)